Phase Ib Study of Ribociclib Plus Fulvestrant and Ribociclib Plus Fulvestrant Plus PI3K-Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer
| Image |  |
|---|---|
| Description | scientific article published on 04 September 2020 |
| Author/s |
author: Thomas Bachelot Ahmed M Abdelhady Emiliano Calvo Sara M Tolaney |
| Publication date | September 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |